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The combined squamous cell carcinoma (SCC) with neuroendocrine (atypical carcinoid (AC)) tumor is extremely rare in the head
and neck.We present here the first case of SCCwithAC arising in the floor of themouth of 65-year-oldman.The tumor is comprised
of two components of SCC and AC in the biopsy specimen. Neuroendocrine tumor component was classified as AC from the
punctate necrosis and 2–10>/10HPF. Immunohistochemical stainingwasHMW-CK/34B (+) andP63 (+) in SCCand synaptophysin
(+) and CD56 (+) in AC. The pathological diagnosis of SCC with AC was made from both the morphological and immunological
exam. Concurrent chemoradiotherapy was performedwith radiotherapy 70.2Gy and chemotherapy of CDDP andVP-16. Although
the treatment effect was complete response both of primary tumor and of neck metastases, the recurrence of the primary tumor
was after 6 months. Bilateral modified radical neck dissection and tumor resection of the floor of the mouth with reconstructive
surgery of anterior lateral thigh free flap were performed. Although the primary and neck tumor did not recur, the multiple lung
metastases and mediastinum lymph node metastases occurred at 6 months after surgery.
1. Introduction
Neuroendocrine neoplasms are a heterogeneous group of
tumors that vary from benign to highly malignant. WHO
(2005) classified neuroendocrine tumor (NET) of the larynx
into 4 types: (1) typical carcinoid, (2) atypical carcinoid (AC),
(3) small cell carcinoma, neuroendocrine type, and (4) com-
bined small cell carcinoma, neuroendocrine type, with non-
small cell carcinoma [1]. The AC (synonyms of malignant
carcinoid, moderately differentiated neuroendocrine carci-
noma, and large cell neuroendocrine carcinoma) is the most
frequent, constituting 54% of all NET in this site, followed by
the small cell carcinoma, neuroendocrine type (34%), para-
ganglioma (9%), and the typical carcinoid (3%) [1]. Although
the NET is a tumor that occurs particularly in the lung
and larynx, oral cavity is a rare site for a primary NET [2].
Recently, neuroendocrine differentiation has also been found
in some tumors not considered to be of neuroendocrine
origin, including squamous cell carcinoma (SCC) of the lung
and esophagus [3, 4]. The occurrence and possible role of
NET in the head and neck SCC have not yet been analyzed.
Combined-type SCC and AC instances in the head and neck
area were reported only in 3 cases and very rare [5–7]. We
report here the fast case of the combined SCC with AC of the
floor of the mouth.
2. Case Report
A 65-year-old Japanese man referred to the Department of
Oral and Maxillofacial Surgery, University of Tsukuba Hos-
pital, complaining of pain in the floor of the mouth for one
month.Hismedical history revealed diabetesmellitus, hyper-
tension, chronic pancreatitis, reflux esophagitis, and iron
deficiency anemia. His face was symmetrical and there was
no trismus. The regional lymph nodes were swollen multiply
in both sides from level I to level II. Intraoral examination
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Figure 1: Intraoral examination shows relatively well defined elastic hard mass with ulcer in the left floor of the mouth, which measures
approximately 36 × 33mm.
Figure 2: T2 weighted MRI sequence shows a 29 × 23 × 22mm heterogeneous high signal mass in the floor of mouth.
Figure 3: Bilateral multiple neck lymph node metastases are shown. The level Ia LNs are swollen in 16mm and 7mm, right level Ib LNs are
swollen in 23mm and 13mm, left level Ib LN is swollen in 5mm, and left level IIa LN is swollen in 37mm.
shows relatively well defined elastic hard mass with necrotic
ulcer in the right to left floor of the mouth, which measures
approximately 36 × 33mm (Figure 1).
T2 weighted MRI showed a sequence that shows a 29 ×
23 × 22mm heterogeneous high signal mass in the floor
of mouth (Figure 2). Bilateral multiple neck lymph node
metastases are depicted in MRI. The level Ia LNs are swollen
in 16mm and 7mm, right level Ib LNs are swollen in 23mm
and 13mm, left level Ib LN is swollen in 5mm, and left level
IIa LN is swollen in 37mm (Figure 3). The 18F-fluorodeoxy-
glucose positron-emission tomography combined with com-
puted tomography (18F-FDG PET/CT) revealed FDG uptake
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Figure 4: (a) The histopathology of biopsy specimen (HE ×40). The square of straight line was comprised of SCC, and dotted line was
comprised of AC. Microscopically, the tumor consists of two components of SCC and AC. (b)The component of SCC. Nonkeratic dysplastic
squamous cells proliferated with apoptosis and mitosis. (c) The component of AC. The cells change in a larger way and have high N/C rate
and chromatin, a lot of mitosis and karyolysises are seen. A punctate necrosis is observed in the tumor nest, and the rosette structures are
observed.
in the floor of the mouth mass measuring 28 × 13mm with
the SUV max 10.4 and bilateral multiple LNs.
The incisional biopsy was performed from floor of the
mouth under local anesthesia. Microscopically, the tumor
consisted of two components of SCC and AC. SCC consisted
of nonkeratic dysplastic squamous cells proliferated with
apoptosis and mitosis. The cells change larger and have high
N/C rate and chromatin, a lot of mitosis and karyolysises
are seen in component of NET. The punctate necrosis was
observed and 2–10>/10HPF.TheNET component was classi-
fied as AC (Figures 4(a)–4(c)). Immunohistochemical stain-
ing was synaptophysin (+), CD56 (+), and chromogranin A
(−) in AC and HMW-CK/34B (+) and P63 (+) in SCC.There
was no transitional part between SCC and AC (Figures 5(a)
and 5(b)). From these findings pathological diagnosis of SCC
with AC in the floor of the mouth was made.
Concurrent chemoradiotherapy was performed with
radiotherapy 70.2Gy and chemotherapy of CDDP and VP-
16 for 4 times under the consideration of unresectable
neck metastases. Chemotherapy regimen was day 1: CDDP
70mg/m2 + VP-16 100mg/m2, day 2: VP-16 100mg/m2, and
day 3: VP-16 100mg/m2. The highest side effects according to
CTCAE ver. 4.0 were leukocytopenia (G4), anemia (G3), and
thrombocytopenia (G3).The aspiration pneumonia occurred
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Figure 5: (a) Immunohistochemical staining shows that the tumor cells are positive for synaptophysin and CD56 in SCC. (b) Immunohisto-
chemical staining shows that the tumor cells are positive for HMW-CK/34B and P63 in SCC.
during pancytopenia after second chemotherapy. The leuko-
cyte counts recovered on administrating of G-CSF and
aspiration pneumonia was improved with the administration
of antibiotics. The treatment effect was complete response
both of primary tumor and of neck metastases.
The recurrence of the primary site occurred 6 months
from the end of chemoradiotherapy with a diagnosis of pri-
mary site biopsy (Figure 6). The volume of lymph node
metastases was decreased and changed to resectable. Bilateral
modified radical neck dissection and tumor resection of the
floor of the mouth with reconstructive surgery of anterior
lateral thigh (ALT) free flap were performed under general
anesthesia. The pathological diagnosis was SCC without AC
in the primary site (Figure 7).There were nometastases in the
specimen of neck lymph nodes. Although the primary and
neck tumor did not recur, the multiple lung metastases and
mediastinum lymph node metastases were diagnosed with
FDG PET at 6 months after surgery (Figure 8). The patient
received best supportive care with chemotherapy of paclitaxel
and cetuximab.
3. Discussion
NETs represent a rare, heterogeneous subset in the laryngeal
malignancies and are classified into distinct groups and
ranging from benign to highly malignant. The oral cavity is a
rare site of a primaryNET and only 12 cases were reported [2].
Figure 6: Intraoral examination 6 months after chemoradiotherapy
shows small ulcer in the left floor of the mouth.
Neuroendocrine differentiation has recently been reported in
SCC of the lung and esophagus. The occurrence and possible
role of neuroendocrine differentiation in the head and neck
SCC have not yet been analyzed [8]. It has been hypothesized
that tumor cells with neuroendocrine characterization may
produce peptides to stimulate tumor growth via autocrine or
paracrine mechanisms [4]. Three previously reported SCC
with AC of head and neck cases were larynx, maxillary sinus,
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Figure 7:The histopathology of recurred resected specimen (HE ×40, ×100). Microscopically, the resected tumor of floor of mouth was SCC.
Figure 8: Lung metastasis and mediastinum lymph node metastases are depicted in the PET-CT.
and upper gingiva [5–7].The present case was the first report
represented on the floor of themouthwith a composite tumor
consisting of SCC and AC. Although the composite tumor
consisted of combined SCC and small cell carcinoma was
reported sometimes, to our knowledge, our case is the fourth
to document a composite tumor including AC [5, 7].
A capacity for multidirectional differentiation could arise
from pluripotent stem cells. SCC and AC could have arisen
from pluripotent cells that differentiated along two distinct
paths or the AC could have differentiated secondarily from
cells arising in SCC [5, 9]. Another hypothesis is that AC
derived from pluripotential indifferent cells of either the
squamous epithelium or the minor salivary gland [10]. In
the present case, there was no transitional part between SCC
and AC in the biopsy specimen, suggested to arise from
pluripotent cells that differentiated along two distinct paths.
Immunohistochemically, NET frequently expresses chro-
mogranin A, synaptophysin, and CD56. The tumor cells of
NET component are positive for synaptophysin and CD56
in our case. The SCC component was negative for synap-
tophysin and CD56 and positive for HMW-CK/34B and
P63. Nisman et al. reported neuroendocrine differentiation
in SCC was associated with poor prognosis [3]. On the other
hand, chromogranin A and synaptophysin expression were
reported not to associate with advanced disease stage and not
to affect patient survival [8]. More cases of this tumor need to
accumulate to clarify biological behavior and prognosis.
The AC most occur in supraglottic submucosal in the
sixth- and seventh-decade males (M : F, 3 : 1). The rate of
metastases was reported 66.7% and the 5-year survival 46%
[10]. There was no evidence for the treatment of head and
neck AC.The primary treatment is reported to be the surgery
and the radiotherapy, with rare response in the chemother-
apy [10]. However, AC is reported to be relatively resis-
tant to chemotherapy and radiation therapy [11], and there
is no proven optimal therapy for metastatic unresectable
AC. Although surgical resection is usually recommended,
patients did respond to radiotherapy and chemotherapy,
suggesting a combined approach may be indicated in the
larynx AC [12]. It was reported that the treatment of primary
neoplasms consisting of more than one histological type is
tailored to themost histologically aggressive tumor [7]. In our
case, the clinical stage was advanced with bilateral multiple
neck lymph node metastasis and the chemoradiotherapy was
selected because of unresectable and aggressive tumor fea-
ture.
Treatment regimens showing efficacy in pulmonary car-
cinoid were reported to include octreotide-based therapies
(10% response rate (RR), 70% disease control rate (DCR)),
etoposide (VP-16) + platinum (23% RR, 69% DCR), and
temozolomide-based therapies (14% RR, 57%DCR) [13].The
regimen for our case was selected as etoposide + platinum,
because platinum is standard regimen for SCC and both
effective for SCC and effective for AC. Fortunately the
chemotherapy with CDDP and VP-16 and radiotherapy were
effective and achieved complete response. The side effect for
CDDP and VP-16 of grade 4 leukocytopenia occurred after
chemotherapy and the aspiration pneumonia occurred dur-
ing pancytopenia. This chemotherapy was tolerable because
the leukocyte counts recovered on administrating of G-CSF
and aspiration pneumonia was improved with antibiotics.
Although the treatment effect was complete response, the
recurrence of the primary site occurred 6 months from the
end of chemoradiotherapy. The resected primary tumor was
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SCC without AC, and there were no tumors in the lymph
nodes. In the reported combined SCC and AC of the lung,
intermediate-grade AC is considered as less aggressive than
SCC. The rapid disease progression was suggested that SCC
component contributes to the metastasis [14]. In the present
case, the component of AC suggested to metastasize to the
lymph nodes and to be sensitive to chemoradiotherapy. The
component of SCC in primary site was not sensitive for
chemoradiotherapy and recurred.
We experienced the first case of SCC with AC of the floor
of mouth. More cases of this tumor need to accumulate to
clarify biological behavior, treatment, and prognosis. More-
over the occurrence and possible role of SCC with AC have
not yet been analyzed, and further research will be desired in
the future.
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